Naomi S Fineberg Selected Research

Naomi S Fineberg Research Topics

Disease

6	Neoplasms (Cancer) 03/2015 - 10/2005
3	Adenocarcinoma 02/2012 - 03/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2011 - 03/2010
3	Shock 11/2002 - 02/2000
2	Infections 04/2014 - 02/2004
2	Hemorrhage 11/2010 - 10/2002
2	Wounds and Injuries (Trauma) 11/2010 - 10/2002
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2005 - 04/2003
1	Cholelithiasis 01/2017
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2017
1	Osteomyelitis 06/2015
1	Rheumatoid Arthritis 04/2014
1	Myelolipoma 11/2013
1	Residual Neoplasm 10/2011
1	Breast Neoplasms (Breast Cancer) 02/2011
1	Body Weight (Weight, Body) 11/2010
1	Hypotension (Low Blood Pressure) 11/2010
1	Hypoglycemia (Reactive Hypoglycemia) 06/2007
1	Internal Hernia 03/2007
1	Fistula 12/2006
1	Lymphoma (Lymphomas) 10/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2005
1	Esophageal Neoplasms (Esophageal Cancer) 04/2005
1	Hypertension (High Blood Pressure) 02/2005
1	Glucose-Galactose Malabsorption 02/2005
1	Neoplasm Metastasis (Metastasis) 01/2005
1	Histoplasmosis 02/2004
1	Fever (Fevers) 02/2004
1	Dyslipidemias (Dyslipidemia) 02/2004
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2004
1	Insulin Resistance 02/2004
1	Mediastinal Diseases 04/2003
1	Glucose Intolerance 08/2002
1	Type 2 Diabetes Mellitus (MODY) 08/2002

Drug/Important Bio-Agent (IBA)

2	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 02/2012 - 10/2011
2	tigatuzumabIBA 02/2012 - 02/2011
2	Metalloproteases (Metalloproteinases)IBA 02/2012 - 10/2011
2	Phosphates (Orthophosphate)IBA 06/2011 - 02/2011
2	Indicators and Reagents (Reagents)IBA 03/2007 - 10/2002
2	Cisplatin (Platino)FDA LinkGeneric 01/2005 - 04/2003
2	Proteins (Proteins, Gene)FDA Link 02/2004 - 08/2002
1	Methicillin (Metin)FDA Link 06/2015
1	VaccinesIBA 03/2015
1	EpitopesIBA 03/2015
1	Environmental CarcinogensIBA 03/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	HydrocarbonsIBA 03/2015
1	9,10-Dimethyl-1,2-benzanthraceneIBA 03/2015
1	Caspase 12IBA 04/2014
1	IodineIBA 11/2013
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2012
1	Contrast MediaIBA 02/2012
1	Matrix Metalloproteinases (MMPs)IBA 10/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2011
1	Cetuximab (Erbitux)FDA Link 06/2011
1	LuciferasesIBA 06/2011
1	ErbB Receptors (EGF Receptor)IBA 06/2011
1	Bevacizumab (Avastin)FDA Link 02/2011
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 02/2011
1	CyclodextrinsIBA 11/2010
1	Insulin AntibodiesIBA 06/2007
1	Insulin (Novolin)FDA Link 06/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2005
1	Carmustine (FIVB)FDA Link 10/2005
1	Etoposide (VP 16)FDA LinkGeneric 10/2005
1	SaltsIBA 02/2005
1	Cytochrome P-450 CYP3AIBA 02/2005
1	glycoprotein phospholipase DIBA 02/2004
1	Triglycerides (Triacylglycerol)IBA 02/2004
1	HDL LipoproteinsIBA 02/2004
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 04/2003
1	brassIBA 10/2002
1	salicylhydroxamic acid (SHAM)IBA 10/2002
1	LipidsIBA 08/2002
1	Plant ProteinsIBA 08/2002
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2002
1	Blood Glucose (Blood Sugar)IBA 08/2002
1	Glucose (Dextrose)FDA LinkGeneric 08/2002

Therapy/Procedure

8	Therapeutics 02/2012 - 01/2005
4	Drug Therapy (Chemotherapy) 06/2011 - 04/2003
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 11/2002 - 02/2000
2	Neoadjuvant Therapy 03/2010 - 04/2005
2	Operative Surgical Procedures 01/2005 - 04/2003
1	Cholecystectomy 01/2017
1	Secondary Prevention 06/2011
1	Pancreaticoduodenectomy 03/2010
1	Glycemic Control 06/2007
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2007
1	Tourniquets 12/2006
1	Hematopoietic Stem Cell Transplantation 10/2005
1	Salvage Therapy 01/2005
1	Catheters 02/2004
1	Transjugular Intrahepatic Portasystemic Shunt 10/2002